Ginseng berry extract prevents atherogenesis via anti-inflammatory action by upregulating phase II gene expression

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Kim, Chun Ki ^a,b   Cho, Dong Hui ^a   Lee, Kyu Sun ^a   Lee, Dong Keon ^a   Park, Chan Woong ^c   Kim, Wan Gi ^c   Lee, Sang Jun ^c   Ha, Kwon Soo ^a   Goo Taeg, Oh ^d   Kwon, Young Guen ^e   Kim, Young Myeong ^a  

^a Kangwon National University   (South Korea)

^b Seoul Medical Center   (South Korea)

^c AmorePacific Corporation   (South Korea)

^d Ewha Womans University   (South Korea)

^e Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; KOREAN GINSENG BERRY EXTRACT; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DRUG ISOLATION; DRUG MECHANISM; GENE; GENE EXPRESSION; GLUTAMINE CYSTEINE LIGASE GENE; HEME OXYGENASE 1 GENE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

EID: 84871380525     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/490301     Document Type: Article

References (47)

1. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 6423 801 809 2-s2.0-0027241856 10.1038/362801a0 (Pubitemid 23132154)
2. Tipping P. G., Hancock W. W., Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. American Journal of Pathology 1993 142 6 1721 1728 2-s2.0-0027751909 (Pubitemid 24057066)
3. Kwak B. R., Mach F., Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arteriosclerosis 2001 21 8 1256 1258 2-s2.0-0035573665 (Pubitemid 34219827)
4. Nam K. W., Kim J., Hong J. J., Choi J. H., Mar W., Cho M. H., Kim Y. M., Oh S. R., Lee H. K., Nam K. H., Oh G. T., Inhibition of cytokine-induced I B kinase activation as a mechanism contributing to the anti-atherogenic activity of tilianin in hyperlipidemic mice. Atherosclerosis 2005 180 1 27 35 2-s2.0-20144386950 10.1016/j.atherosclerosis.2004.11.022
5. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P. A., Neumeier D., Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. Journal of Clinical Investigation 1996 97 7 1715 1722 2-s2.0-13344261982 (Pubitemid 26105480)
6. Buttery L. D. K., Springall D. R., Chester A. H., Evans T. J., Standfield N., Parums D. V., Yacoub M. H., Polak J. M., Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Laboratory Investigation 1996 75 1 77 85 2-s2.0-0029895815 (Pubitemid 26250275)
7. Galkina E., Ley K., Vascular adhesion molecules in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 11 2292 2301 2-s2.0-36048979880 10.1161/ATVBAHA.107.149179 (Pubitemid 350203942)
8. Vallabhapurapu S., Karin M., Regulation and function of NF- B transcription factors in the immune system. Annual Review of Immunology 2009 27 693 733 2-s2.0-67650724069 10.1146/annurev.immunol.021908.132641
9. Surh Y. J., Kundu J. K., Na H. K., Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Medica 2008 74 13 1526 1539 2-s2.0-56249106571 10.1055/s-0028-1088302
10. Park S. H., Jang J. H., Chen C. Y., Na H. K., Surh Y. J., A formulated red ginseng extract rescues PC12 cells from PCB-induced oxidative cell death through Nrf2-mediated upregulation of heme oxygenase-1 and glutamate cysteine ligase. Toxicology 2010 278 1 131 139 2-s2.0-78149415856 10.1016/j.tox.2010.04. 003
11. Chen J. S., Huang P. H., Wang C. H., Lin F. Y., Tsai H. Y., Wu T. C., Lin S. J., Chen J. W., Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract. Atherosclerosis 2011 214 2 301 309 2-s2.0-79151485932 10.1016/j.atherosclerosis.2010.11.010
12. Lü J. M., Yao Q., Chen C., Ginseng compounds: an update on their molecular mechanisms and medical applications. Current Vascular Pharmacology 2009 7 3 293 302 2-s2.0-69149110615 10.2174/157016109788340767
13. Attele A. S., Wu J. A., Yuan C. S., Ginseng pharmacology: multiple constituents and multiple actions. Biochemical Pharmacology 1999 58 11 1685 1693 2-s2.0-0344549853 10.1016/S0006-2952(99)00212-9 (Pubitemid 29505408)
14. Dey L., Xie J. T., Wang A., Wu J., Maleckar S. A., Yuan C. S., Anti-hyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine 2003 10 6-7 600 605 2-s2.0-0041336976 10.1078/094471103322331908 (Pubitemid 37092688)
15. Attele A. S., Zhou Y. P., Xie J. T., Wu J. A., Zhang L., Dey L., Pugh W., Rue P. A., Polonsky K. S., Yuan C. S., Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002 51 6 1851 1858 2-s2.0-0036266324 (Pubitemid 34564298)
16. Kim Y. K., Yoo D. S., Xu H., Park N. I., Kim H. H., Choi J. E., Park S. U., Ginsenoside content of berries and roots of three typical Korean ginseng (Panax ginseng) cultivars. Natural Product Communications 2009 4 7 903 906 2-s2.0-70349573509
17. Kim J. H., Na H. J., Kim C. K., Kim J. Y., Ha K. S., Lee H., Chung H. T., Kwon H. J., Kwon Y. G., Kim Y. M., The non-provitamin A carotenoid, lutein, inhibits NF- B-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF- B-inducing kinase pathways: role of H2O2 in NF- B activation. Free Radical Biology and Medicine 2008 45 6 885 896 2-s2.0-54949129134 10.1016/j.freeradbiomed.2008.06.019
18. Lee G., Na H. J., Namkoong S., Jeong Kwon H., Han S., Ha K. S., Kwon Y. G., Lee H., Kim Y. M., 4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF- B-DNA-binding activity. European Journal of Pharmacology 2006 551 1-3 143 151 2-s2.0-33750479072 10.1016/j.ejphar.2006. 08.061 (Pubitemid 44648048)
19. Jeon H. J., Choi J. H., Jung I. H., Park J. G., Lee M. R., Lee M. N., Kim B., Yoo J. Y., Jeong S. J., Kim D. Y., Park J. E., Park H. Y., Kwack K., Choi B. K., Kwon B. S., Oh G. T., CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 2010 121 9 1124 1133 2-s2.0-77949352851 10.1161/CIRCULATIONAHA.109.882704
20. Kuhn A. M., Tzieply N., Schmidt M. V., Von Knethen A., Namgaladze D., Yamamoto M., Brüne B., Antioxidant signaling via Nrf2 counteracts lipopolysaccharide-mediated inflammatory responses in foam cell macrophages. Free Radical Biology and Medicine 2011 50 10 1382 1391 2-s2.0-79955467291 10.1016/j.freeradbiomed.2011.02.036
21. Bae Y. S., Oh H., Rhee S. G., Yoo Y. D., Regulation of reactive oxygen species generation in cell signaling. Molecules and Cells 2011 32 6 491 509
22. Lin J. H. C., Zhu Y., Liao H. L., Kobari Y., Groszek L., Stemerman M. B., Induction of vascular cell adhesion molecule-1 by low-density lipoprotein. Atherosclerosis 1996 127 2 185 194 2-s2.0-0030596089 10.1016/S0021-9150(96) 05951-5 (Pubitemid 27045832)
23. Hwang S. Y., Son D. J., Kim I. W., Kim D. M., Sohn S. H., Lee J. J., Kim S. K., Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytotherapy Research 2008 22 6 778 783 2-s2.0-46849103623 10.1002/ptr.2363 (Pubitemid 351955576)
24. Siegel R. K., Ginseng and high blood pressure. Journal of the American Medical Association 1980 243 1 32 2-s2.0-0018921765 (Pubitemid 10212030)
25. Joo I. W., Ryu J. H., Oh H. J., The influence of Sam-Chil-Geun (panax notoginseng) on the serum lipid levels and inflammations of rats with hyperlipidemia induced by poloxamer-407. Yonsei Medical Journal 2010 51 4 504 510 2-s2.0-77956193982 10.3349/ymj.2010.51.4.504
26. Ishibashi T., Takeishi Y., Ezetimibe and vascular inflammation. Current Vascular Pharmacology 2011 9 1 99 108 2-s2.0-78650963071 10.2174/ 157016111793744788
27. Gutiérrez S. H., Kuri M. R., del Castillo E. R., Cardiac role of the transcription factor NF- B. Cardiovascular and Hematological Disorders 2008 8 2 153 160 2-s2.0-48249109930 10.2174/187152908784533702
28. Leung P. O., Wang S. H., Lu S. H., Chou W. H., Shiau C. Y., Chou T. C., Simvastatin inhibits pro-inflammatory mediators through induction of heme oxygenase-1 expression in lipopolysaccharide-stimulated RAW264. 7 macrophages. Toxicology Letters 2011 207 2 159 166
29. Mantovani A., Bussolino F., Dejana E., Cytokine regulation of endothelial cell function. FASEB Journal 1992 6 8 2591 2599 2-s2.0-0026725537
30. Libby P., Ridker P. M., Hansson G. K., Inflammation in Atherosclerosis. From Pathophysiology to Practice. Journal of the American College of Cardiology 2009 54 23 2129 2138 2-s2.0-70450189795 10.1016/j.jacc.2009.09.009
31. Mazière C., Mazière J. C., Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radical Biology and Medicine 2009 46 2 127 137 2-s2.0-58049095209 10.1016/j. freeradbiomed.2008.10.024
32. Lee S. J., Bai S. K., Lee K. S., Namkoong S., Na H. J., Ha K. S., Han J. A., Yim S. V., Chang K., Kwon Y. G., Lee S. K., Kim Y. M., Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I B kinase-dependent NF- B activation. Molecules and Cells 2003 16 1 97 105 2-s2.0-3042742915 (Pubitemid 41582907)
33. Wu M. L., Ho Y. C., Lin C. Y., Yet S. F., Heme oxygenase-1 in inflammation and cardiovascular disease. American Journal of Cardiovascular Disease 2011 1 2 150 158
34. Hayes J. D., Flanagan J. U., Jowsey I. R., Glutathione transferases. Annual Review of Pharmacology and Toxicology 2005 45 51 88 2-s2.0-12844268268 10.1146/annurev.pharmtox.45.120403.095857 (Pubitemid 40261798)
35. Hadad N., Levy R., The synergistic anti-inflammatory effects of lycopene, lutein, β -carotene, and carnosic acid combinations via redox-based inhibition of NF- B signaling. Free Radical Biology and Medicine 2012 53 7 1381 1391
36. Chen J. H., Ou H. P., Lin C. Y., Lin F. J., Wu C. R., Chang S. W., Tsai C. W., Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chemical Research in Toxicology 2012 25 9 1893 1901
37. Sun Q., Meng Q. T., Jiang Y., Xia Z. Y., Ginsenoside Rb1 attenuates intestinal ischemia reperfusion induced renal injury by activating Nrf2/ARE pathway. Molecules 2012 17 6 7195 7205
38. Wang L., Zhang Y., Wang Z., Li S., Min G., Wang L., Chen J., Cheng J., Wu Y., Inhibitory effect of ginsenoside-Rd on carrageenan-induced inflammation in rats. Canadian Journal of Physiology and Pharmacology 2012 90 2 229 236
39. Wang J., Qiao L., Li Y., Yang G., Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion- induced liver injury by inhibiting NF-kappaB activation. Experimental & molecular medicine 2008 40 6 686 698 2-s2.0-64949154470
40. Zhang Z., Li X., Lv W., Yang Y., Gao H., Yang J., Shen Y., Ning G., Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor- B. Molecular Endocrinology 2008 22 1 186 195 2-s2.0-38049063954 10.1210/me.2007-0119
41. Juulink B. H., Dietary Nrf2 activators inhibit atherogenic processes. Atherosclerosis 2012 225 1 29 33 10.1016/j.atherosclerosis.2012.08.032
42. Li W., Khor T. O., Xu C., Shen G., Jeong W. S., Yu S., Kong A. N., Activation of Nrf2-antioxidant signaling attenuates NF B-inflammatory response and elicits apoptosis. Biochemical Pharmacology 2008 76 11 1485 1489 2-s2.0-55949120110 10.1016/j.bcp.2008.07.017
43. Chapple S. J., Siow R. C., Mann G. E., Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. International Journal of Biochemistry and Cell Biology 2012 44 8 1315 1320
44. Kim J. H., Choi Y. K., Lee K. S., Cho D. H., Baek Y. Y., Lee D. K., Ha K. S., Choe J., Won M. H., Jeoung D., Lee H., Kwon Y. G., Kim Y. M., Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA. Free Radical Biology and Medicine 2012 53 3 629 640
45. Ishikawa K., Sugawara D., Wang X. P., Suzuki K., Itabe H., Maruyama Y., Lusis A. J., Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circulation Research 2001 88 5 506 512 2-s2.0-0035896220 (Pubitemid 32240914)
46. Cheng C., Noordeloos A. M., Jeney V., Soares M. P., Moll F., Pasterkamp G., Serruys P. W., Duckers H. J., Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 2009 119 23 3017 3027 2-s2.0-67649557000 10.1161/CIRCULATIONAHA.108.808618
47. Li T., Tian H., Zhao Y., An F., Zhang L., Zhang J., Peng J., Zhang Y., Guo Y., Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of atherosclerosis. European Journal of Pharmacology 2011 672 1-3 143 152